Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. The Dow Jones Industrial Average ( ^DJI) is trading up 14 points at 15,893 as of Monday, Jan 27, 2014, 1:35 p.m. ET. During this time, 291.7 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 358.9 million. The NYSE advances/declines ratio sits at 624 issues advancing vs. 2,389 declining with 116 unchanged.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be Travelers Companies (NYSE: TRV), which is sporting a $1.29 gain (+1.6%) bringing the stock to $82.90. This single gain is lifting the Dow Jones Industrial Average by 9.76 points or roughly accounting for 69.7% of the Dow's overall gain. Volume for Travelers Companies currently sits at 2.4 million shares traded vs. an average daily trading volume of two million shares. Travelers Companies has a market cap of $30.24 billion and is part of the financial sector and insurance industry. Shares are down 9.9% year to date as of Friday's close. The stock's dividend yield sits at 2.4%. The Travelers Companies, Inc., through its subsidiaries, provides various commercial and personal property and casualty insurance products and services to businesses, government units, associations, and individuals primarily in the United States. The company has a P/E ratio of 8.8, below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Travelers Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.